NIH has started the Production of Cell Culture Rabies Vaccine (CCRV)

The National Institute of Health (NIH) has restarted the production of Cell Culture Rabies Vaccine (CCRV). The vaccine is presently on completion stages of Quality Control analysis and lot release process.

NIH assures to Ministry of National Health Services Regulation & Coordination (NHSR&C) that it shall utilize all the resources to meet the country’s need of vaccines and anti-sera productions.  The production of anti-Rabies Vaccine would be available in the public-sector health services department by February, 2019.